Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Progression in multiple sclerosis is associated with low endogenous NCAM.
Fertility, Pregnancy and Childbirth in Patients with Multiple Sclerosis: Impact of Disease-Modifying Drugs.
Cardiovascular effects of fingolimod: A review article.
Prediction of disability progression in fingolimod-treated patients.
Computer-aided cognitive rehabilitation improves cognitive performances and induces brain functional connectivity changes in relapsing remitting multiple sclerosis patients: an exploratory study.
Possible Role of Staphylococcal Enterotoxin B in the Pathogenesis of Autoimmune Diseases.
Treatment satisfaction and improvement in health-related quality of life with onabotulinumtoxinA in patients with urinary incontinence due to neurogenic detrusor overactivity.
A 3-year Multi-center Study to Describe Changes of OCT Parameters Under Treatment With Gilenya® (PASSOS)
Diagnostic Efficacy of Conventional MRI Pulse Sequences in the Detection of Lesions Causing Internuclear Ophthalmoplegia in Multiple Sclerosis Patients.
Identification of biomarkers in cerebrospinal fluid and serum of multiple sclerosis patients by immunoproteomics approach.
Early detection and favourable outcome of natalizumab-related progressive multifocal leukoencephalopathy (PML) in two multiple sclerosis patients.
A simple score for estimating the long-term risk of fracture in patients with multiple sclerosis.
Transplantation of olfactory ensheathing cells promotes partial recovery in rats with experimental autoimmune encephalomyelitis.
The ICF as a framework to collect and interpret data on the extent and variety of disability in neurological conditions.
Sustained TNF production by central nervous system infiltrating macrophages promotes progressive autoimmune encephalomyelitis.
Longitudinal Change in Physical Activity and Its Correlates in Relapsing-Remitting Multiple Sclerosis.
IM interferon beta-1a delays definite multiple sclerosis 5 years after a first demyelinating event.
Regulatory T cell proliferative potential is impaired in human autoimmune disease.
Tumefactive demyelination following herbal supplement use: Cause or coincidence?
Features of Virchow-Robin spaces in newly diagnosed multiple sclerosis patients.
Prorating WAIS-IV Summary Scores for Patients with Relapsing-Remitting Multiple Sclerosis.
Helicobacter pylori infection as a protective factor against multiple sclerosis risk in females.
A metabonomics investigation of multiple sclerosis by nuclear magnetic resonance.
Association of fish consumption and omega 3 supplementation with quality of life, disability and disease activity in an international cohort of people with multiple sclerosis.
The effectiveness of aerobic training, cognitive behavioural therapy, and energy conservation management in treating MS-related fatigue: the design of the TREFAMS-ACE programme.
Pages
« first
‹ previous
…
359
360
361
362
363
364
365
366
367
…
next ›
last »